Literature DB >> 23476119

AED Treatment Through Different Ages: As Our Brains Change, Should Our Drug Choices Also?

Jacqueline A French1, Brigid A Staley.   

Abstract

Patient age can impact selection of the optimal antiepileptic drug for a number of reasons. Changes in brain physiology from neonate to elderly, as well as changes in underlying etiologies of epilepsy, could potentially affect the ability of different drugs to control seizures. Unfortunately, much of this is speculative, as good studies demonstrating differences in efficacy across age ranges do not exist. Beyond the issue of efficacy, certain drugs may be more or less appropriate at different ages because of differing pharmacokinetics, including changes in hepatic metabolism, absorption, and elimination. Lack of appropriate drug formulations (such as liquid forms) may be a barrier to using drugs in the very young. Finally, some serious adverse events are seen either exclusively or preferentially at different ages.

Entities:  

Year:  2012        PMID: 23476119      PMCID: PMC3588149          DOI: 10.5698/1535-7511-12.4s.22

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  34 in total

1.  Variation in antiepileptic drug adherence among older patients with new-onset epilepsy.

Authors:  John E Zeber; Laurel A Copeland; Mary Jo V Pugh
Journal:  Ann Pharmacother       Date:  2010-11-02       Impact factor: 3.154

Review 2.  Special needs of the adolescent with epilepsy.

Authors:  D R Nordli
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

3.  Drug treatment of neonatal seizures by neonatologists and paediatric neurologists.

Authors:  Kathryn Browning Carmo; Peter Barr
Journal:  J Paediatr Child Health       Date:  2005-07       Impact factor: 1.954

4.  Developmental factors in the pathogenesis of neonatal seizures.

Authors:  Frances E Jensen
Journal:  J Pediatr Neurol       Date:  2009-01-01

Review 5.  Initial treatment of epilepsy with antiepileptic drugs: pediatric issues.

Authors:  Raman Sankar
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein.

Authors:  Scott Mintzer; Christopher T Skidmore; Caitlin J Abidin; Megan C Morales; Inna Chervoneva; David M Capuzzi; Michael R Sperling
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Pharmacokinetics of valproic acid in the elderly.

Authors:  E Perucca; R Grimaldi; G Gatti; S Pirracchio; F Crema; G M Frigo
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 8.  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

Review 9.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; P B Pennell; B S Koppel; C A Hovinga; B Gidal; K J Meador; J Hopp; T Y Ting; W A Hauser; D Thurman; P W Kaplan; J N Robinson; J A French; S Wiebe; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; P O Shafer; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

10.  Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Authors:  P B Pennell; L Peng; D J Newport; J C Ritchie; A Koganti; D K Holley; M Newman; Z N Stowe
Journal:  Neurology       Date:  2007-11-28       Impact factor: 9.910

View more
  5 in total

1.  Anti-Epileptic Drugs in Geriatric Neurosurgery: A Review of 669 Neurosurgical Cases.

Authors:  Omar Al-Taei; Abdulrahman Al-Mirza; Humaid Al Kalbani; Mohammed Ali; Tariq Al-Saadi
Journal:  J Epilepsy Res       Date:  2022-06-30

2.  Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription.

Authors:  Colin B Josephson; Jordan D T Engbers; Nathalie Jette; Scott B Patten; Shaily Singh; Tolulope T Sajobi; Deborah Marshall; Yahya Agha-Khani; Paolo Federico; Aaron Mackie; Sophie Macrodimitris; Brienne McLane; Neelan Pillay; Ruby Sharma; Samuel Wiebe
Journal:  JAMA Neurol       Date:  2019-04-01       Impact factor: 18.302

3.  Epilepsy in the elderly: Special considerations and challenges.

Authors:  Jayant N Acharya; Vinita J Acharya
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

4.  6 Hz Active Anticonvulsant Fluorinated N-Benzamide Enaminones and Their Inhibitory Neuronal Activity.

Authors:  Isis J Amaye; Thomas Heinbockel; Julia Woods; Zejun Wang; Miguel Martin-Caraballo; Patrice Jackson-Ayotunde
Journal:  Int J Environ Res Public Health       Date:  2018-08-20       Impact factor: 3.390

Review 5.  Acute symptomatic seizures and status epilepticus in older adults: A narrative review focusing on management and outcomes.

Authors:  Wan Yee Kong; Rohit Marawar
Journal:  Front Neurol       Date:  2022-08-26       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.